TOP STORIES
respiratory
Asthma

Targeting Type 2 inflammation: treating the common denominator


Type 2 inflammation is emerging as a unifying feature of multiple inflammatory diseases, including asthma. As part of the ADVENT Advances in Type 2 Inflammatory Diseases medical education series run by Sanofi Genzyme, allergy specialist and immunologist Professor Connie Katelaris...

Type 2 inflammation is emerging as a unifying feature of multiple inflammatory diseases, including asthma. As part of the ADVENT...

Read more